Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ET
Company Participants
Jennifer Good – Co-Founder, President and Chief Executive Officer
Lisa Delfini – Chief Financial Officer
Conference Call Participants
Faisal Khurshid – Leerink Partners
Mayank Mamtani – B. Riley
Annabel Samimy – Stifel
Leland Gershell – Oppenheimer
Serge Belanger – Needham & Company
Ryan Deschner – Raymond James
Brandon Folkes – Rodman & Renshaw
Christian Cubides – Clear Street
Operator
Good afternoon and welcome to the Trevi Therapeutics Fourth Quarter and Year End 2024 Earnings Conference Call. At this time, all participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.
Various remarks that management makes during this conference call about the company’s future expectations, plans and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in the Risk Factors section of the company’s most recent annual report on Form 10-K, which the company filed with the SEC this afternoon.
In addition, any forward-looking statements represent the company’s views only as of today and should not be relied upon as representing the company’s views as of any subsequent date. While the company may elect to update these forward-looking statements at some point in the future, the company specifically disclaims any obligation to do so even if its views change.
I would now like to turn the conference over to Jennifer Good, Trevi’s President and CEO. Please go ahead.
Jennifer Good
Good afternoon and thank you for joining us for our fourth quarter and
Read the full article here